Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ghobadi Moghaddam-Helmantel IM"'
Autor:
Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands. Electronic address: s.buck@erasmusmc.nl., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Ghobadi-Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Lam MH; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2023 Jun 01; Vol. 1225, pp. 123752. Date of Electronic Publication: 2023 May 26.
Autor:
Buck SAJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. s.buck@erasmusmc.nl., Guchelaar NAD; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Oct; Vol. 61 (10), pp. 1471-1473. Date of Electronic Publication: 2022 Jul 27.
Autor:
Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, P.O. Box 2040, 3000CA Rotterdam, The Netherlands., Braal CL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hofman MM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hussaarts KGAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Vastbinder MB; Department of Internal Medicine, IJsselland Hospital, Capelle aan den IJssel, The Netherlands., van Rossum-Schornagel QC; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The NetherlandsDepartment of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Mar 17; Vol. 14, pp. 17588359221081075. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Autor:
Huisman SA; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., IJzermans JN; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., Wiemer EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Bruin RW; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2016 Mar; Vol. 173 (5), pp. 804-14. Date of Electronic Publication: 2016 Feb 08.
Autor:
Nieuweboer AJ; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Hu S; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Gui C; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Hagenbuch B; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Ghobadi Moghaddam-Helmantel IM; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Gibson AA; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., de Bruijn P; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Mathijssen RH; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri a.mathijssen@erasmusmc.nl., Sparreboom A; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, MissouriAuthors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri.
Publikováno v:
Cancer research [Cancer Res] 2014 Jun 01; Vol. 74 (11), pp. 3137-45. Date of Electronic Publication: 2014 Apr 22.
Autor:
Binkhorst L; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Mathijssen RH, Ghobadi Moghaddam-Helmantel IM, de Bruijn P, van Gelder T, Wiemer EA, Loos WJ
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2011 Dec 15; Vol. 56 (5), pp. 1016-23. Date of Electronic Publication: 2011 Aug 05.
Autor:
Konings IR; Department of Medical Oncology, Erasmus University Medical Center, Room HE-118, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. i.konings@erasmusmc.nl, Sleijfer S, Mathijssen RH, de Bruijn P, Ghobadi Moghaddam-Helmantel IM, van Dam LM, Wiemer EA, Verweij J, Loos WJ
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2011 May; Vol. 67 (5), pp. 1055-62. Date of Electronic Publication: 2010 Jul 23.